At last, a clue to where cancer metastases are born

May 2, 2017, The Scripps Research Institute
On the left, stained red blood vessels weave between florescent green tumor cells. On the right, the researchers have mapped exactly where tumor cells (white) have entered blood vessels. The image shows that more cells enter blood vessels in the tumor's core than its invasive border. Credit: Elena Deryugina and William Kiosses

Even in remission, cancer looms. Former cancer patients and their doctors are always on alert for metastatic tumors. Now scientists at The Scripps Research Institute (TSRI) have discovered why some cancers may reoccur after years in remission.

The findings, published recently in the journal Cell Reports, show that invasive tumors can begin sending out far earlier than previously thought. These escaping —which can enter the bloodstream before the primary is detected—may seed secondary tumors that don't show up for years.

Importantly, the scientists demonstrated that the escaping tumor cells reach the bloodstream by entering blood vessels deep within the dense tumor core, upending the long-held belief that metastatic cells come from a tumor's invasive borders.

"The actual process of cell dissemination via hematogenous routes is a relatively under-studied process, but we finally have an answer as to where it takes place," said TSRI Assistant Professor Elena Deryugina, who led the study in a long-term collaboration with TSRI Staff Scientist William Kiosses.

Metastasis Appears to Start Early

Doctors typically describe tumors in four stages: A solid tumor is more or less confined during stages 0 and 1, but starts invading nearby tissues at stage 2. It is believed that the tumor begins to send the cells to distant organs only after extensive invasion into the adjacent stroma (a nearby tissue or organ) at stage 3. Stage 4 is usually associated with the presence of secondary tumors described as metastases.

In their new study, the researchers wanted to take a closer look at this conventional view of cancer cell spread.

Using cancer cell lines generated from human fibrosarcoma and carcinoma tumors, the researchers found that primary tumors can send out cells early on—independent of cancer invasion into adjacent tissue. This could explain why doctors often see secondary tumors appearing earlier than they would have predicted.

This finding may also shed light on why patients with early stage tumors still have a risk of developing metastatic disease. "These metastases may have been seeded when the primary tumor was even too small to be visualized," Deryugina said.

Peering through dense primary tumors had been a roadblock in cancer studies until now, and this new discovery was possible because the researchers developed of animal models that allowed for microscopic analysis of tumor cell dissemination. Specifically, adapted mouse ear and chick embryo models let the scientists examine developing tumors through relatively thin tissue layers.

Cancer Cells Escape from Tumor Core

The new study is also the first to examine entire tumors to find out exactly where escaping cells come from. The scientists tagged human tumor cells with a florescent protein to distinguish them from the cells of a tumor-bearing animal. Using high-resolution confocal microscopy techniques spearheaded by Kiosses, the researchers mapped in 3-D all blood vessels across entire tumors, from the tumors' dense cores to their invasive tendrils.

The researchers mapped the location of every tumor cell relative to the center of the closest blood —or visualized within blood vessels. This approach gave the researchers a way to finally analyze the escape process, called intravasation, and to demonstrate where intravasating cells enter blood vessels.

The researchers were surprised by what they found: The vast majority of tumor cells entered blood vessels within the tumor core, not in the invasive tendrils.

This discovery challenges the long-held assumption that tumor cells enter the bloodstream only after they invade adjacent stroma and reach tumor-converging blood vessels. Instead, the researchers found that fewer than 10 percent of escaped cells intravasated from the stroma-invading sprouts.

This makes sense, Deryugina said, because the newly formed vessels in the tumor core are ideal highways for escaping tumor cells.

A 2015 study by Deryugina and TSRI colleagues showed that these new vessels in the tumor core are structurally sound but permeable enough to give tumor cells a chance to slip into the bloodstream for a ride to other areas of the body. In contrast, blood vessels converging on the tumor border are less welcoming—their walls are more mature and almost impossible for tumor cells to break through.

Deryugina said it has been extremely satisfying to finally discover the primary location where tumor cells intravasate, even if the data contradict conventional cancer models.

This finding could be important for cancer patients. The research suggests a primary tumor does not have to be highly invasive to seed metastases. In fact, doctors may want to reconsider the time frame for the onset of cancer cell dissemination. While are more likely to manifest intravasation, the two processes—intravasation and invasion—appear to be independent of each other.

The researchers also found that levels of a protein called EGFR could be a good indicator of whether tumor cells would intravasate. EGFR appeared to regulate a tumor's ability to induce that support cancer cell escape. "Therefore, the data indicate the importance of harnessing the EGFR activity early on in cancer patients," said Deryugina.

Next, the researchers plan to investigate the functional roles of different cell types within a , such as inflammatory leukocytes, which also may be critically important for supporting intratumoral cancer cell intravasation.

The study, "Intratumoral Cancer Cell Intravasation Can Occur Independent of Invasion into the Adjacent Stroma," was supported by the National Institutes of Health (grants R01CA105412, R01CA129484 and R01CA157792).

Explore further: Study suggests tumors may 'seed' cancer metastases earlier than expected

More information: Elena I. Deryugina et al, Intratumoral Cancer Cell Intravasation Can Occur Independent of Invasion into the Adjacent Stroma, Cell Reports (2017). DOI: 10.1016/j.celrep.2017.03.064

Related Stories

Study suggests tumors may 'seed' cancer metastases earlier than expected

October 29, 2015
A new study from scientists at The Scripps Research Institute (TSRI) helps explain why cancer metastasis is so hard to stop.

Research supports an alternate theory of how tumors metastasize

August 16, 2016
Scientists at the California NanoSystems Institute at UCLA have taken a major step toward confirming an unusual theory of how some cancer cells metastasize. Their findings may lead to new strategies for keeping melanoma from ...

Cancer cells' transition can drive tumor growth, researchers find

December 21, 2016
As cancerous tumors fester in the body, they need an ever-increasing blood supply to deliver the oxygen and nutrients that fuel their growth. Now, a team led by University of Florida Health researchers has established how ...

Silencing cancer cell communication may reduce the growth of tumors

January 30, 2017
In several types of cancer, elevated expression of the chemokine receptor CCR4 in tumors is associated with poor patient outcomes. Communication through CCR4 may be one mechanism that cancer cells use to create a pro-tumor ...

Restoring flawed tumor vessels could lead to better cancer treatments

November 17, 2016
Researchers led by Peter Carmeliet (VIB-KU Leuven) have found a novel way to normalize the dysfunctional blood vessels that are typical for tumors. Those vessels play a pivotal role in cancer metastasis, as their fragility ...

Uncovering the mechanisms that support the spread of ovarian cancer

October 10, 2016
A very high mortality rate is associated with ovarian cancer, in part due to difficulties in detecting and diagnosing the disease at early stages before tumors have spread, or metastasized, to other locations in the body.

Recommended for you

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

NEJM reports positive results for larotrectinib against TRK-fusion cancer

February 22, 2018
In 2013, the labs of University of Colorado Cancer Center investigator Robert C. Doebele, MD, PhD, and Dana-Farber Cancer Institute investigator Pasi A. Jänne, MD, PhD reported in Nature Medicine the presence of TRK gene ...

New therapeutic gel shows promise against cancerous tumors

February 21, 2018
Scientists at the UNC School of Medicine and NC State have created an injectable gel-like scaffold that can hold combination chemo-immunotherapeutic drugs and deliver them locally to tumors in a sequential manner. The results ...

Five novel genetic changes linked to pancreatic cancer risk

February 21, 2018
In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.